Le Lézard
Classified in: Health
Subjects: SCZ, FVT

Brookdale to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference


NASHVILLE, Tenn., May 13, 2020 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or the "Company") announced today that Lucinda "Cindy" Baier, President and Chief Executive Officer and Steven Swain, Executive Vice President and Chief Financial Officer will participate in a discussion regarding the Company at the 2020 RBC Capital Markets Global Healthcare Virtual Conference on Wednesday, May 20, 2020. 

The Brookdale discussion will begin at 9:10 am ET and the live audio webcast can be accessed on the Internet through the Company's website at www.brookdale.com/investor as well as directly at  http://www.veracast.com/webcasts/rbc/healthcare2020/91202394773.cfm. A replay of the webcast will be available on the Company's website until August 18, 2020. 

About Brookdale Senior Living
Brookdale Senior Living Inc. is the leading operator of senior living communities throughout the United States.  The Company is committed to providing senior living solutions primarily within properties that are designed, purpose-built and operated to provide the highest-quality service, care and living accommodations for residents.  Brookdale operates and manages independent living, assisted living, memory care and continuing care retirement centers, with 741 communities in 45 states and the ability to serve approximately 65,000 residents as of March 31, 2020.  The Company also offers a range of home health, hospice and outpatient therapy services to over 20,000 patients as of that date.  Brookdale's stock is traded on the New York Stock Exchange under the ticker symbol BKD.

SOURCE Brookdale Senior Living Inc.


These press releases may also interest you

at 05:25
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...

at 05:11
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...

at 04:31
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...



News published on and distributed by: